Holen Sie sich die Stockscreener-App
14.71
1.57%
-0.235
Handel nachbörslich:
14.71
0.005
+0.03%
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
Chart based exit strategy for Rapport Therapeutics Inc.Weekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
How hedge fund analytics apply to Rapport Therapeutics Inc. stockTrade Performance Summary & Weekly High Potential Alerts - Newser
JonesTrading Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $42 - 富途牛牛
What data driven models say about Rapport Therapeutics Inc.’s futureQuarterly Portfolio Report & Verified Momentum Stock Watchlist - Newser
Rapport Therapeutics Inc. stock prediction for this weekQuarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
XTX Topco Ltd Buys Shares of 15,442 Rapport Therapeutics, Inc. (NASDAQ:RAPP) - Defense World
Q3 EPS Forecast for Rapport Therapeutics Cut by Analyst - Defense World
Can Rapport Therapeutics Inc. hit a new high this monthMarket Rally & Entry Point Confirmation Alerts - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsInflation Watch & Low Drawdown Investment Ideas - Newser
How to manage a losing position in Rapport Therapeutics Inc. [Profit Target]Risk Controlled Swing Trade Alerts - Newser
Will Rapport Therapeutics Inc. rebound enough to break evenFree Reliable Chart-Based Trade Entries - Newser
Published on: 2025-08-12 21:34:00 - Newser
How to manage a losing position in Rapport Therapeutics Inc.Strategy Builder for Growth Focused Traders - Newser
Published on: 2025-08-12 06:02:16 - Newser
Why Rapport Therapeutics Inc. stock attracts strong analyst attentionSecure Asset Flow and Trend Pattern Analysis - Newser
What momentum shifts mean for Rapport Therapeutics Inc.Reversal Signal Prediction Based on Volume - Newser
Market reaction to Rapport Therapeutics Inc.’s recent newsTrade Safety Matrix for Conservative Traders - Newser
What Fibonacci levels say about Rapport Therapeutics Inc. reboundFree Multi-Bagger Potential Stock Forecast Tools - Newser
Intraday pattern recognizer results for Rapport Therapeutics Inc.Free Capital Protection Trading Strategies - Newser
Rapport Therapeutics Inc.’s volatility index tracking explainedMarket Downturn Defense Strategy Analysis - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayReal Time Trade Execution Alert Plan - Newser
Chart overlay techniques for tracking Rapport Therapeutics Inc.Short-Term Growth Watch with Signal Prediction - Newser
What is HC Wainwright’s Estimate for RAPP Q2 Earnings? - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at HC Wainwright - Defense World
Rapport Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Rapport Therapeutics' Q2 2025 Update: RAP-219's Precision Neuroscience Potential and September 2025 Catalyst - AInvest
Rapport (RAPP) Q2 Net Loss Widens 47% - AOL.com
Rapport Therapeutics reports Q2 EPS (75c), consensus (79c) - TipRanks
Rapport Therapeutics sees cash runway through end of 2026 - TipRanks
Rapport Therapeutics Reports Q2 2025 Financials and Business Update. - AInvest
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update - GlobeNewswire
Press Release: Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update - 富途牛牛
Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
HC Wainwright Initiates Rapport Therapeutics at Buy With $31 Price Target - MarketScreener
Is Rapport Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Community Entry Consensus Trade Ideas - Newser
0.44%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):